HMG
Published Research
PubMed-indexed studies for HMG
Human menopausal gonadotropin (HMG) combined different doses of letrozole for treating anovulatory infertility in patients with polycystic ovary syndrome: a randomized controlled trial.
View on PubMed →Human recombinant follicle stimulating hormone (rFSH) compared to urinary human menopausal gonadotropin (HMG) for ovarian stimulation in assisted reproduction: a literature review and cost evaluation.
View on PubMed →Comparison of recombinant human luteinising hormone (r-hLH) and human menopausal gonadotropin (hMG) in assisted reproductive technology.
View on PubMed →The human menopausal gonadotropin (hMG) dose in in vitro fertilization (IVF): what is the optimal dose?
View on PubMed →Analytical Investigation of the Profile of Human Chorionic Gonadotropin in Highly Purified Human Menopausal Gonadotrophin Preparations.
View on PubMed →Human Menopausal Gonadotropin Commenced on Early Follicular Period Increases Live Birth Rates in POSEIDON Group 3 and 4 Poor Responders.
View on PubMed →Research-Grade HMG
⚠️ For laboratory research only. Not for human use.

